Page last updated: 2024-11-07

1-(3-trifluoromethylphenyl)-2-propanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-(3-trifluoromethylphenyl)-2-propanol: metabolite of fenfluramine; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID150791
SCHEMBL ID2421761
MeSH IDM0114031

Synonyms (21)

Synonym
1-tfmpp
L001044
1-[3-(trifluoromethyl)phenyl]propan-2-ol
621-45-4
benzeneethanol, alpha-methyl-3-(trifluoromethyl)-
1-(3-trifluoromethylphenyl)-2-propanol
AKOS011901019
1-(3-(trifluoromethyl)phenyl)propan-2-ol
1-(3-trifluoromethylphenyl)-propan-2-ol
SCHEMBL2421761
1-[3-(trifluoromethyl)phenyl]propanol-2-(4-(trifluoromethyl)phenyldimethyl carbinol)
1-[3-(trifluoromethyl)phenyl]-2-propanol
1-(3-trifluoromethyl)phenyl-1-propanol
ES-2665
DTXSID10977693
FT-0778265
alpha-methyl-3-(trifluoromethyl)phenethyl alcohol
phenethyl alcohol, alpha-methyl-m-(trifluoromethyl)-
T889FRK2V5
alpha-methyl-3-(trifluoromethyl)benzeneethanol
EN300-1932599
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (66.67)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.25 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]